
Core Viewpoint - Biote Corp. (BTMD) shares have increased by 1.3% recently, closing at $5.39, with a potential upside indicated by Wall Street analysts' mean price target of $9.54, suggesting a 77% increase [1] Price Targets and Estimates - The mean price target is based on five short-term estimates with a standard deviation of $1.12, where the lowest estimate is $8 (48.4% increase) and the highest is $11 (104.1% increase) [2] - A low standard deviation indicates a strong agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [7] Earnings Estimates - Analysts are optimistic about BTMD's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which has shown a strong correlation with near-term stock price movements [9] - Over the past 30 days, two earnings estimates have increased, leading to a 46.2% rise in the Zacks Consensus Estimate for the current year [10] Zacks Rank - BTMD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential upside [11] Conclusion on Price Targets - While consensus price targets may not reliably indicate the extent of BTMD's potential gains, they do provide a useful guide for the direction of price movement [12]